Katzenellenbogen Mark, Pappo Orit, Barash Hila, Klopstock Naama, Mizrahi Lina, Olam Devorah, Jacob-Hirsch Jasmine, Amariglio Ninette, Rechavi Gidi, Mitchell Leslie Ann, Kohen Ron, Domany Eytan, Galun Eithan, Goldenberg Daniel
Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel.
Cancer Res. 2006 Apr 15;66(8):4001-10. doi: 10.1158/0008-5472.CAN-05-2937.
Molecular events preceding the development of hepatocellular carcinoma were studied in the Mdr2-knockout (Mdr2-KO) mice. These mice lack the liver-specific P-glycoprotein responsible for phosphatidylcholine transport across the canalicular membrane. Portal inflammation ensues at an early age followed by hepatocellular carcinoma development after the age of 1 year. Liver tissue samples of Mdr2-KO mice in the early and late precancerous stages of liver disease were subjected to histologic, biochemical, and gene expression profiling analysis. In an early stage, multiple protective mechanisms were found, including induction of many anti-inflammatory and antioxidant genes and increase of total antioxidant capacity of liver tissue. Despite stimulation of hepatocyte DNA replication, their mitotic activity was blocked at this stage. In the late stage of the disease, although the total antioxidant capacity of liver tissue of Mdr2-KO mice was normal, and inflammation was less prominent, many protective genes remained overexpressed. Increased mitotic activity of hepatocytes resulted in multiple dysplastic nodules, some of them being steatotic. Expression of many genes regulating lipid and phospholipid metabolism was distorted, including up-regulation of choline kinase A, a known oncogene. Many other oncogenes, including cyclin D1, Jun, and some Ras homologues, were up-regulated in Mdr2-KO mice at both stages of liver disease. However, we found no increase of Ras activation. Our data suggest that some of the adaptive mechanisms induced in the early stages of hepatic disease, which protect the liver from injury, could have an effect in hepatocarcinogenesis at later stages of the disease in this hepatocellular carcinoma model.
在Mdr2基因敲除(Mdr2-KO)小鼠中研究了肝细胞癌发生之前的分子事件。这些小鼠缺乏负责将磷脂酰胆碱转运过胆小管膜的肝脏特异性P-糖蛋白。幼年时会出现门静脉炎症,1岁后会发生肝细胞癌。对处于肝病癌前早期和晚期的Mdr2-KO小鼠的肝组织样本进行了组织学、生化和基因表达谱分析。在早期,发现了多种保护机制,包括许多抗炎和抗氧化基因的诱导以及肝组织总抗氧化能力的增加。尽管刺激了肝细胞DNA复制,但它们的有丝分裂活性在此阶段被阻断。在疾病后期,尽管Mdr2-KO小鼠肝组织的总抗氧化能力正常,炎症也不那么明显,但许多保护基因仍过度表达。肝细胞有丝分裂活性增加导致多个发育异常结节,其中一些是脂肪变性的。许多调节脂质和磷脂代谢的基因表达发生扭曲,包括已知的癌基因胆碱激酶A的上调。在肝病的两个阶段,Mdr2-KO小鼠中许多其他癌基因,包括细胞周期蛋白D1、Jun和一些Ras同源物,都上调了。然而,我们发现Ras激活没有增加。我们的数据表明,在肝病早期诱导的一些保护肝脏免受损伤的适应性机制,在这个肝细胞癌模型中可能在疾病后期的肝癌发生过程中发挥作用。